In addition, it is now intriguing to speculate that loss-of-function mutations in the Ptx3 gene might represent a genetic risk factor for pulmonary manifestations of human SLE or that recombinant PTX3 or other PTX3 agonists might have the potential to specifically suppress autoimmune lung disease. This evidence concerns the gene PTX3 and systemic lupus erythematosus.